The extraordinary growth and specialization that has occurred in the sciences has made it difficult to link the increasing divide between clinical and basic science components of ophthalmic and vision sciences. Translational research has suffered as a consequence. The Harvard Department of Ophthalmology is one of the largest academic departments of Ophthalmology in the nation. With over 130 full-time clinical and basic science faculty members, it makes significant contributions to ophthalmic and vision research in virtually all basic, applied, and clinical subspecialty areas. The Harvard Department of Ophthalmology K12 program offers a customized and structured learning, research, and development environment to a select and diverse group of highly-qualified, clinically-trained candidates who have recently completed (or are about to complete) their training, but who desire further mentored learning experience so as to become independent clinical scientists in their respective fields. Scholar candidates in this program will (i) complete a core curriculum that will include (a) the Harvard Program in Clinical Effectiveness - a summer-long immersion program in biostatistics and epidemiology, and study design, (b) Neurobiology 300 "Biologic Bases of Ophthalmic Disease", a multidisciplinary survey course focusing on the cellular and molecular mechanisms of eye disease, (c) training in Responsible Conduct of Research and Bioethics. and (d) participation in Grant Writing courses. Scholars will also (ii) perform research in a closely mentored program under the guidance of lead mentors who are leaders in their respective fields. Trainees in this program will additionally have the option of seeking an advanced degree (MS, MPH, PhD, ScD) at Harvard. This is a competitive renewal application for the Harvard Ophthalmology K12 program, which has been very successful to date in meeting its benchmarks of recruiting and training top-notch clinician-scientists in a mentored environment. Since 2005, the program has received 69 inquiries, from which 20 were invited to complete the formal application process. Of these 20 applicants, five (25%) were accepted into the program, including 3 women Scholars. Scholars in the program have been highly productive in research, have completed or enrolled in degree programs, and received national academic and research awards and grants. Three of the early entrants are applying for R01 grants in 2009. The progress of Scholars is reported by the Program Director twice annually to the Program Advisory Committee and annually to the External Advisory Committee, comprised of leading vision and ophthalmic scientists and educators in our nation.
Our aim i s to build on our progress to date, and continue our training program for an additional 5 years.

Public Health Relevance

The goal of the Harvard-Vision Clinical Scientist Development Program is to provide an academically rich and supportive environment to enable qualified early-stage clinician-scientists to engage in a structured and mentored learning experience that will enable them to achieve career advancement and independence through a rigorous program of didactic courses, research, and other development activities.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12EY016335-09
Application #
8655869
Study Section
Special Emphasis Panel (ZEY1-VSN (10))
Program Officer
Agarwal, Neeraj
Project Start
2004-09-30
Project End
2016-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
9
Fiscal Year
2014
Total Cost
$1,099,416
Indirect Cost
$82,723
Name
Massachusetts Eye and Ear Infirmary
Department
Type
DUNS #
073825945
City
Boston
State
MA
Country
United States
Zip Code
02114
Arnoldner, Michael A; Kheirkhah, Ahmad; Jakobiec, Frederick A et al. (2014) Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole. Cornea 33:747-9
Kim, Leo A; Amarnani, Dhanesh; Gnanaguru, Gopalan et al. (2014) Tamoxifen toxicity in cultured retinal pigment epithelial cells is mediated by concurrent regulated cell death mechanisms. Invest Ophthalmol Vis Sci 55:4747-58
Bitrian, Elena; Song, Brian J; Caprioli, Joseph (2014) Bleb revision for resolution of hypotony maculopathy following primary trabeculectomy. Am J Ophthalmol 158:597-604.e1
Valdez, Cammi N; Arboleda-Velasquez, Joseph F; Amarnani, Dhanesh S et al. (2014) Retinal microangiopathy in a mouse model of inducible mural cell loss. Am J Pathol 184:2618-26
Sobrin, Lucia; Seddon, Johanna M (2014) Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res 40:1-15
Schrems-Hoesl, L M; Schrems, W A; Cruzat, A et al. (2013) Cellular and subbasal nerve alterations in early stage Fuchs' endothelial corneal dystrophy: an in vivo confocal microscopy study. Eye (Lond) 27:42-9
Faez, Sepideh; Loewenstein, John; Sobrin, Lucia (2013) Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy. JAMA Ophthalmol 131:113-5
Hamrah, Pedram; Cruzat, Andrea; Dastjerdi, Mohammad H et al. (2013) Unilateral herpes zoster ophthalmicus results in bilateral corneal nerve alteration: an in vivo confocal microscopy study. Ophthalmology 120:40-7
Yamaguchi, Takefumi; Turhan, Aslihan; Harris, Deshea L et al. (2013) Bilateral nerve alterations in a unilateral experimental neurotrophic keratopathy model: a lateral conjunctival approach for trigeminal axotomy. PLoS One 8:e70908
Bagchi, Mandrita; Kim, Leo A; Boucher, Jeremie et al. (2013) Vascular endothelial growth factor is important for brown adipose tissue development and maintenance. FASEB J 27:3257-71

Showing the most recent 10 out of 28 publications